A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies

Pharmacy World and Science

Volumn 30, Issue 2, 2008, Pages 147-153

  Benrimoj, Shalom I ^a   Werner, Joel B ^a   Raffaele, Catherine ^a   Roberts, Alison S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Australia; Community pharmacy; Non prescription medicines; OTC; Pseudo patient; Quality assurance

Indexed keywords

NON PRESCRIPTION DRUG;

AUSTRALIA; CONSUMER; DECISION MAKING; DRUG MONITORING; DRUG QUALITY; FEEDBACK SYSTEM; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; METHODOLOGY; NOTE; PHARMACY; RISK ASSESSMENT; SAFETY; STANDARD;

AUSTRALIA; COMMUNITY PHARMACY SERVICES; COUNSELING; DRUGS, NON-PRESCRIPTION; GUIDELINE ADHERENCE; HUMANS; MANAGEMENT AUDIT; PATIENT SIMULATION; PHARMACISTS; PHARMACISTS' AIDES; PROCESS ASSESSMENT (HEALTH CARE); PROFESSIONAL COMPETENCE; PROFESSIONAL-PATIENT RELATIONS; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE;

EID: 39749191875     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9162-7     Document Type: Note

References (27)

1. Australian Government Department of Health and Ageing. The national strategy for quality use of medicines. Commonwealth of Australia, Canberra, 2002. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/nmp-pdf- natstrateng-cnt.htm/$FILE/natstrateng.pdf. Accessed Oct 2004.
2. Government of New South Wales. Poisons and therapeutic goods act 1966, 2004. http://www.legislation.nsw.gov.au/maintop/scanact/inforce/NONE/0
3. National Coordinating Committee on Therapeutic Goods (NCCTG). A report to the Australian health ministers' conference on the results of the research into a cost-benefit analysis and risk assessment of pharmacist only (S3) and pharmacy medicines (S2) and risk-based evaluation of the standards. Canberra: Australian Government Department of Health and Ageing; 2005.
4. Australian Self-Medication Industry. Self care in Australia: the foundation for a healthy nation. 2005. http://www.asmi.com.au
5. Therapeutic Goods Administration. NDPSC Record of reasons. 2003. http://www.health.gov.au/tga/ndpsc/records.htm
6. World Self-Medication Industry. Legal status of selected ingredients worldwide. 2004. http://wsmi.org/otc.htm
7. Benrimoj SI. A cost-benefit analysis of pharmacist only (S3) and pharmacy medicines (S2) and risk based evaluation of the standards [Final report]. University of Sydney. 2005.
8. Galbally R. National competition review of drugs, poisons and controlled substances legislation (final report), in council of Australian governments review. 2001.
9. Benrimoj SI, Gilbert A, Qunitrell N, de Almeida Neto AC. Non-prescription medicines: a process for standards development and testing in community pharmacy. Pharm World Sci 2007;29:386-94.
10. Benrimoj SI, Wilson F. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy (Revised, November 2005), In: Professional Practice Standards (Version 3), editor. Canberra: The Pharmaceutical Society of Australia; 2006.
11. The Pharmacy Guild of Australia. Quality care pharmacy program. 1998.
12. The Commonwealth Department of Health and Ageing. Third community pharmacy agreement between the commonwealth of Australia and the pharmacy guild of Australia. 2000.
13. Pharmaceutical Society of Australia. Professional practice standards (Version 3). Curtin: Pharmaceutical Society of Australia; 2006.
14. The Pharmacy Guild of Australia, QCPP major program changes. 2003. http://www.qcpp.com/program_changes.htm
15. The Pharmacy Guild of Australia. 2006. http://www.qcpp.com/ accreditations_for_about_QCPP.htm. Accessed January 2006.
16. The Commonwealth Department of Health and Ageing. Fourth community pharmacy agreement between the commonwealth of Australia and the pharmacy guild of Australia. 2005.
17. de Almeida Neto AC, Benrimoj SI, Kavanagh DJ, Boakes RA. Novel educational training program for community pharmacists. Am J Pharm Educ 2000;64:302-7.
18. Watson MC, Norris P, Granas A. A systematic review of the use of simulated patients and pharmacy practice research. Int J Pharm Pract 2006;14(2):83-93.
19. Benrimoj SI, Werner JB, Raffaele C, Costa FA, Roberts AS. Monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies: results of a national program. Qual Saf Health Care. 2007 [in press].
20. Benrimoj SI, Raffaele C, Werner JB. Improving the quality of service delivered by Australian community pharmacies in the management of non-prescription medicines: a pseudo-patron study [Abstract]. In: International social pharmacy workshop, Oxford; 2006.
21. Watson MC, Skelton JR, Bond CM, Croft P, Wiskin CM, Grimshaw JM et al. Simulated patients in the community pharmacy setting. Pharm World Sci 2004;26:32-7.
22. Watson MC, Bond CM, Grimshaw JM, Johnston M. Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting. Qual Saf Health Care 2006;15:53-7.
23. Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther 2005;30(1):45-57.
24. Puumalainen II, Peura SH, Kansanaho HM, Benrimoj CS, Airaksinen MS. Progress in patient counselling practices in finnish community pharmacies. Int J Pharm Pract 2005;13(2):149-56.
25. Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists' and pharmacist assistants' practice in dealing with direct requests for non-prescription analgesics. Int J Pharm Pract 2002;10(1):23-9.
26. Watson MC, Bond CM, Grimshaw JM, Mollison J, Ludbrook A, Walker AE. Educational strategies to promote evidence-based community pharmacy practice: a cluster randomized controlled trial (RCT). Fam Pract 2002;19:529-36.
27. Australian Health Ministers' Advisory Council. Guidelines for national drugs and poisons schedule committee. 1997.